Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudomembranous colitis: an update.

H S Brar1, C M Surawicz

  • 1Harborview Medical Center, Seattle, WA 98104, USA.

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|February 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ursodiol for all?

The American journal of gastroenterology·2002
Same author

Infectious causes of chronic diarrhea.

Gastroenterology clinics of North America·2001
Same author

Anal warts and anal cancer.

The American journal of gastroenterology·2001
Same author

Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: incidence, causes, and outcome.

The American journal of gastroenterology·2001
Same author

The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Ulcerative colitis and cytomegaloviral esophagitis: two diseases, two randomized, controlled trials.

Current gastroenterology reports·2000
Same journal

Evaluation of funding gastroenterology research in Canada illustrates the beneficial role of partnerships.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

Treatment of chronic hepatitis C in a Canadian Aboriginal population: results from the PRAIRIE study.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

Improving the quality of colonoscopy bowel preparation using an educational video.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

Putting an end to the misuse of the fecal occult blood test in diagnostic medicine.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
See all related articles

Clostridium difficile infection, a common hospital-acquired gastrointestinal illness, is often linked to antibiotic use. Diagnosis involves stool tests, with enzyme-linked immunoassays offering a rapid screening option for C. difficile toxins.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Clostridium difficile is a leading cause of nosocomial gastrointestinal infections.
  • Antibiotic therapy disrupts normal gut flora, enabling C. difficile overgrowth and toxin production.
  • Accurate diagnosis is crucial for effective treatment and management.

Purpose of the Study:

  • To review diagnostic methods for Clostridium difficile infection.
  • To discuss therapeutic strategies for C. difficile disease and recurrence.
  • To highlight the role of Saccharomyces boulardii in managing recurrent infections.

Main Methods:

  • Review of diagnostic tests including stool culture, cytotoxin assays, and enzyme-linked immunoassays (ELISA).
  • Evaluation of treatment guidelines for C. difficile infection, including metronidazole and vancomycin.

Related Experiment Videos

  • Assessment of biotherapeutic approaches for recurrent C. difficile, focusing on Saccharomyces boulardii.

    • Main Results:

    • No single diagnostic test is perfect; ELISA offers rapid screening for C. difficile toxins A and/or B.
    • Metronidazole is the first-line therapy; vancomycin is reserved for severe or refractory cases.
    • Recurrent C. difficile infections pose a clinical challenge, often requiring retreatment and adjunct therapies.

    Conclusions:

    • Effective management of Clostridium difficile infection involves appropriate diagnostic testing and tailored therapeutic interventions.
    • Saccharomyces boulardii shows promise as an adjunct therapy to prevent C. difficile recurrence.
    • Further research into optimal treatment strategies for recurrent C. difficile infections is warranted.